Prevalence, risk factors and diagnostic accuracy of non-invasive tests for NAFLD in people with type 1 diabetes
Source
JHEP Reports - ISSN 2589-5559-5:7 (2023) p. 1-12
Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH
Source
Journal of hepatology - ISSN 0168-8278-78:3 (2023) p. 479-492
Clinical significance and impact of gastric non-Helicobacter pylori Helicobacter species in gastric disease
Source
Alimentary pharmacology and therapeutics - ISSN 0269-2813- (2023) p. 1-13
A multistakeholder approach to innovations in NAFLD care
Source
Communications medicine - ISSN 2730-664X-3:1 (2023) p. 1-5
A cross-sectional analysis of the association between testosterone and biopsy-proven non-alcoholic fatty liver disease in men with obesity
Source
Endocrine - ISSN 1355-008X- (2023) p. 1-10